Said in CommitteeBeta

Exactly as spoken.

House Public Health, Welfare and Labor Committee

March 26, 2015
Video Transcript

Bills discussed (5)

Bill Title Sponsor Status
HB1162 · 2 mentions in transcript
Matched: “…guson, you're recognized to concur your Senate amendment on House Bill 1162.”
Pre-2017 bill
SB754 · 2 mentions in chapter, transcript
Matched: “SB754”
Pre-2017 bill
SB600 · 1 mention in chapter
Matched: “SB600”
Pre-2017 bill
SB717 · 1 mention in chapter
Matched: “SB717”
Pre-2017 bill
SB927 · 1 mention in chapter
Matched: “SB927”
Pre-2017 bill

Official video page ↗

Transcript

Transcript available Whisper ✓ SliQ live captions: not yet available Download .txt
Machine transcript

May contain errors. Verify important quotations against the official video.

About transcript accuracy
Source
Whisper
Model
ggml-large-v3-turbo.bin RTX5060
Processing date
October 15, 2026
All right. We still have more people coming over from budget. The first thing we're going to do is first order of business, of course, is Senator Johnson's bill, but we need to concur in Senate amendment real quick, so it won't take but a moment, and it'll allow more people to get here to hear the testimony as well. So, Representative Ferguson, you're recognized to concur your Senate amendment on House Bill 1162.
▶ Play
Thank you, Mr. Chair and committee. This won't take but a minute. This is Senator Irving and I were on this bill for graduate registered physicians to allow someone who didn't match in the residency to work in a doctor's office. And Senator Irving caught it on the other end. It should have said board eligible instead of just board certified because for two reasons. It's a lengthy process to get board certified sometime for sergeants. Sometime they had to practice three or four years before they could even take the board. And then some of the older family practice doctors graduated before kind of the board certification thing became a big deal. So it would really facilitate getting people out to rural areas to be able to work in a doctor's office. So that's all it does, just change one word from board certified to board eligible. Members, any questions
▶ Play
Speaker 5 1:16
on that amendment? Seeing or hearing none, what's the wheel
▶ Play
of the committee? We have a motion to adopt or to concur, I'm sorry, to concur the Senate amendment on House Bill 1162. all in favor say aye. Aye. Any opposed? All right thank you Representative Ferguson. Thank you. Senator Johnson I think we're ready to get started and Representative Lundstrom are you going to go to the end table as well? Okay.
▶ Play
Speaker 13 1:40
Chair would it be okay if I stay here and and get Phil Harris and Director Bissett to come to the end of the table? Absolutely. Just kind of I
▶ Play
think all members were here at the last meeting where we kind of left off on this. This is almost kind of like version number two, not version number two, but day two of this hearing, if you will. Where we kind of left off, if I can kind of ask a question and get started, where we kind of left off, there was an idea to try to get a fiscal impact, which we feel like is going to be virtually impossible. But I know you all did some work toward that direction. Do you want to kind
▶ Play
Speaker 13 2:18
of update us on that? Well, if I could get the director and Phil Harris to come to the end of the table, I think they can better address that. All right. It's Daryl
▶ Play
Bassett and Phil Harris. Is that right? Yes, sir. All right. If you all would, obviously, I think you've done this before, introduce yourself for the record, and you're recognized to give testimony as best, help us out on this issue as best as you can.
▶ Play
Speaker 21 2:44
Thank you, Mr. Chairman, members of the committee. I'm Daryl Bassett, director of DWS. First of all, I want to certainly give credit to Senator. Mr. Bassett.
▶ Play
Speaker 23 2:53
Director of what? Director of DWS. Department
▶ Play
Speaker 24 2:56
of Workforce Services. Thank you, sir. Excuse
▶ Play
Speaker 21 2:59
me, sir. Excuse me, sir. Acronyms will kill us all. They will, won't they? Yes, sir. They will. First of all, I want to certainly give credit to Senator Johnson for the concept of this bill. We have no problem with the concept of this bill. We've worked with him on this bill. He's made a number of adjustments and amendments to this bill to bring it in line with what we think we are capable of doing at DWS, as well as bring it in line with what's going on nationwide. Of course, the large issue was the uncertainty in the courts surrounding this type of operation. But he has made those commitments, those amendments that we think are necessary. But, of course, the fiscal impact, as you just aptly mentioned, is still very much an issue. We're looking at now, with our current process, just what we have on hand now. This is going to be in the neighborhood of $1.75 million to do this initially. Of course, our current staff is not capable of performing the necessary services with regard to this type of testing, so we would need to seek outside contractual assistance in order to do that. Because of the timing issue here, we certainly have not been able to secure numbers there, so we're looking at something certainly far north of $2 million at the very least in that regard. Mr. Harris, who is the assistant director in charge of TANF, has specifics with regard to what comprises those, and so we'll certainly be open to questions. But that is the issue right now is certainly the cost and then where we're going to get the money. Clearly, one of the provisions of TANF, two provisions of TANF I want to highlight. First of all, the first provision does not prevent us from doing this kind of testing. That needs to be made clear. But secondly, the program is not allowed to incur any of the medical expenses that may result from this. Many of these participants or clients, as we like to refer to them, qualify for Medicaid, and so that would be an option for them. For those individuals that don't, in some instances, rare instances, SSI may be utilized. In those instances where neither of those apply, then those individuals would not be covered to any extent. Members, any questions for Mr. Bissett before we move
▶ Play
over to Mr. Harris? That kind of, I guess, helped a little bit anyway. Mr. Harris, would you like to introduce yourself for the record and your recognized gift testimony? Yes, sir.
▶ Play
Speaker 30 6:01
Good. I'm Phil Harris, Assistant Director for the TANF program at the Department of Workforce Services.
▶ Play
Speaker 28 6:08
Basically, I'll just ditto what Director Busset
▶ Play
Speaker 30 6:11
just alluded to. I think we've taken the information in the bill or in the legislation, the proposed legislation, and to the best of our ability, we've estimated the number of applications, the number of applications, and the number of recipients, border county applications, border county recipients. And then the legislation also proposed possibly a 10% non-border county application and non-border recipients. I think that has been adjusted. So those numbers would be adjusted accordingly. But, again, the estimate, we looked at the cost of the screening, the cost of the testing, the cost of training our staff, the cost of infrastructure, the cost of computer application. We would have to update our IT system as well to track these individuals as they go through, which is part of the proposed legislation. So I'll just stop there, and that gives the background of the numbers and how we came up with the numbers.
▶ Play
Thank you, Mr. Harrison. So the very definition of TANF is temporary assistance for needy families. Can you give me an idea on how temporary that is? How long is someone ordinarily receiving that
▶ Play
Speaker 30 7:39
assistance? The federal timeline for the TANF program is five years, 60 months. Arkansas has elected a 24-month timeline for the TANF program. I will say that the average T, as we call in Arkansas, TANF is the block grant, T is our actual program, Transitional Employment Assistance. The average length of time a participant is on the T program is 11 months.
▶ Play
Okay, so these are folks that aren't even typically receiving the program for a year at a time then. They're usually able to find something and get going again. That is correct. Okay. Members, questions? Seeing none. Senator
▶ Play
Speaker 13 8:27
Johnson? We do have an amendment to this. Should we address that now?
▶ Play
I didn't recognize. I thought we'd adopted an amendment last time. I guess not. Okay, so we have an amendment. I guess it's on the tablets. We probably should deal with that right now. So, members, there's an amendment on your tablets.
▶ Play
Speaker 13 8:54
Would you like to explain that amendment, Senator Johnson? The amendment is coming from the AG's office and the workforce services and also the governor's office to make this a better bill. And it strikes that 10% language and puts it at the department's discretion. And it also, just a second, instead of having consent language on page five, line five, it is those who took the test. And, you know, that could be some of that court issue where that, you know, it's consent or not consent. So that language was stricken, and that's pretty much what it does.
▶ Play
And that that amendment addresses some of the problems I'd heard yes before it ever got down to this end So that's good. I think it sounds as good amendment to me members any questions on the amendment itself We have motion to adopt the amendment any discussion Okay, all in favor say Any opposed? The amendment is adopted. You're now presenting the bill as amended
▶ Play
For those of you who may not have been here yesterday, this amendment or this bill is designed to do a pilot program only before a lot of money is spent statewide, and what we're asking is that whoever controls the funds for that family be drug tested. If they test positive, the funds for that family would still go to them, only the person in control of those funds would change. That's it. We just want to make sure that the funds are actually getting to the children. If someone is using drugs, that needs to be addressed as well. It isn't very flashy. It's only a small pilot program, and it's only on suspicion of. So while the cost at the initial is going to be a little bit high, yes, we're only going to test at suspicion of. We're not going to test everybody, and it's only going to be in border counties. So it's very small. I open it to Florida questions.
▶ Play
Members, you've heard a presentation of the bill as amended. Do we have any questions from members? Representative Bragg, you're recognized for a question. I just want to
▶ Play
clarify, as far as the funding, it's just if money becomes available, right?
▶ Play
Okay, thank you. Seeing no further questions, we have one person signed up to speak against this, and that's Marquita Little. If you'd like to come to the end of the table and find a spot, there we go. Mr. Bassett will give you his spot. If you would introduce yourself for the record, as you did on Tuesday, and you're recognized to give testimony. It's nice to
▶ Play
Speaker 48 11:47
meet you. Thank you, Mr. Chair and members of the committee for hearing from me again today. I'm Marquita Little. I'm the Health Policy Director with Arkansas Advocates for Children and Families. And so I think most of you heard my testimony previously, and so I'll try to be brief today. I just want to really restate a few of the key points for consideration and as well as present just a little bit more new information Tennessee was highlighted as an example state and so I wanted to share a little bit of information about their process and the results that they've seen to date so first just start by saying although this bill would create a pilot some of the same concerns still remain regarding implementation of any type of program that would require drug testing for public assistance benefits. You heard an estimate of what the actual cost would be for our state, but what is not included in those costs, again, like many other states, have faced many years of lengthy and costly litigation. Much of the subject of that litigation has been around the notion of what is considered to be reasonable suspicion. For Florida, for example, that was four years of litigation. Also, you heard from me in talking about the effectiveness of this type of drug testing, and it is not. It's been demonstrated that it's not very effective based on other state experience. In Florida, only 2.5% of applicants who were tested actually tested positive. In Indiana, 1% of those who were tested actually tested positive. These type of drug tests really are focused on or really based on oftentimes flawed assumptions that there is a higher percentage of drug use amongst low-income families, many families who are really just working very hard to overcome difficult economic times. You've also, again, heard a bit about the expense, and so I just want to highlight the actual cost of implementing these types of programs based on estimates from SAMHSA, the federal agency, the Substance Abuse and Mental Health Services Administration. Average cost of test range between $25 and $75. So back to my Florida example, where only 2.5% of applicants tested positive, the range of the cost to identify one person who actually tested positive is between $1,000 and $3,000 per person. In Indiana, where they spent $45,000 to test about 1,200 people, the cost range was on average about $3,500 to root out one person who was identified as an actual drug user. So, again, although this is a pilot, we have sufficient evidence from other state experience that demonstrate this type of program yields very low results at a high cost in terms of the actual state dollars that are spent. Very important to highlight is also the fact that these types of drug testing programs can be dangerous, really, and bad for low-income families and children. Even in those cases where protective payee language is included in terms of another individual being able to legally receive those benefits, I still have concerns and questions around if that will reduce the overall household benefits that are coming in because that adult who tested positive may no longer be considered in the count of what the household size is. Another key point to reiterate is that even when you are making referrals for treatment There is a concern, a major concern That this bill doesn't actually help families pay for that treatment And ensure that they receive treatment Medicaid was identified as a potential option for many of those adults And I think it's important to note that traditional Medicaid Has very limited coverage for substance abuse treatment services For adults in the state of Arkansas We are currently operating in a system in our state where the capacity of substance use disorder treatment providers has not caught up with the changes in the insurance market. So extremely concerned that we would be essentially making referrals to people who then have to wait another six months to a year before they can actually access that important treatment. And so if this is a primary purpose of that bill, then these state dollars may be better spent on actually ensuring that we have appropriate treatment options for people who actually require access to that type of treatment. And so finally I just want to provide a little bit more information on Tennessee's experience since that is one of our neighboring states. That was used as an example of a state that's currently implementing a similar program. So just a little bit about the actual process that they use. So the Tennessee law went into effect July 1, 2014, and it requires TANF applicants to respond basically to three questions as a part of the screening process because, remember, you have to actually establish some reasonable cause for testing them. So they answered three short questions about their basically recent drug use. If they have used any of the following drugs, have you lost or been denied employment, and also had any legal involvement related to use of drugs. Based on their response to those questions, if they say yes, then those folks are flagged to be screened for drug use. So in the first six months, between July 1 and December 1, here are some of the results from Tennessee. About 16,000 people actually applied for benefits during that time period. Based on their responses to those three questions, only 279 answered yes and were screened. Of those 279, only 37 actually tested positive for drug use. And so while that's something around 13% of the actual 279, when you look at the 16,000 people who actually applied for benefits, That only identified less than 1%. The actual number is somewhere around 0.2% of all applicants who actually tested positive. Another 81 people were denied benefits because they dropped out of the application process. They didn't want to actually complete the application process. Well, even when you add those 81, it's still 0.7%. So less than 1% of all 16,000 applicants in Tennessee either were screened positive or failed to complete the application process. So I think that's very important in considering the cost that this would add to the state, the stigma that this places on low-income families when we're thinking about passing this bill. less than 1% of 16,000 applicants in Tennessee actually were denied or did not receive some level of benefits because of this. Thank you. Members, any questions
▶ Play
for Ms. Little? Representative Henderson, you're recognized. Ms.
▶ Play
Little, I think me and you may look at things a little bit different. Representative Henderson,
▶ Play
you and that microphone need to become better friends.
▶ Play
it scares me sorry thanks miss little uh i guess we look at things just a little bit different and everybody's going to have their own perspective but when when you're looking at at 37 cases in tennessee that actually lost their benefits uh from this drug testing could couldn't you assume though that drug testing is kind of a deterrent for people to do it and maybe the people that would actually get out and do drugs think a little different. If I was on drugs and I knew that I had to come in here and Speaker Link was going to drug test me, I'd probably get in a little earlier that night and not do it. Can you see where that could Be a benefit to what we're doing?
▶ Play
Speaker 48 20:18
So I think if the primary purpose is to identify people who have a need for substance use disorder treatment, there are much more effective ways to do that. I also think if there is an adult in the household who does require that type of support and need, that probably it would be really critical and concerning to potentially reduce their benefits in some way while they are receiving that treatment, and if I could for a moment just speak from personal experience prior to my career in health policy, I worked as a behavioral health interventionist. I worked as an in-home family counselor and clinical supervisor in both Arkansas and Tennessee. I went into the homes of many of the families who are eligible for and receive low-income families who receive TANF benefits, worked with families to budget on little to no income, teaching them how to appropriately spend those dollars that they are receiving, helped people do things like figure out how to purchase a bus pass to actually get to the job training that is a part of many of the TANF programs. And I can say with almost 100% certainty, most people who are in that position and earning a very, very low income, there is little concern from my personal experience and from the research and data that they are any more likely to be using drugs than members of the general population. And in addition, quite honestly, for those folks who are, not receiving your monthly benefits is little deterrent for them. Yes, sir, go ahead. But if
▶ Play
I got the bill right, it's not going to – you're just changing who's in charge of those funds that you're sending it to. I think the purpose of this bill is to make sure that the funds get in the right place. And when you look at Tennessee with 279 people, is that right, tested, and 37 are caught, I would think that would be a success because you are deterring people from actually using drugs. You know, it's not always the addict that you're, you know, when you look at addicts, you know, those people aren't going to change. And I would just assume when you're looking at 37 people that got tested and was positive, that's something that you're not going to change. I think what this bill addresses is what you really do want to change is the people, maybe more of a recreational, that you can go in and they know they have consequences for their actions.
▶ Play
Speaker 48 23:38
And so if I could just briefly share another figure from Tennessee The 37 people who tested positive And so of the 0.2% of the population that actually tested positive Only 5 actually enrolled in a drug treatment program And so I would also defer to maybe a clinician to speak more To what is the appropriate intervention for someone who is dealing with a substance use disorder treatment, but I think it's worth noting that of the 37 people, only five actually enrolled, and so clearly there are some issues in terms of the breakdown between identifying people and ensuring that they actually get access to treatment, so I still would have to respectfully disagree with you in that this would actually deter someone who is actively using drugs, or even in identifying them. All right. Let me get to Representative
▶ Play
Overby and fight, and I'll come back to you.
▶ Play
Thanks. Representative Overby, you're recognized. Thank you, Mr. Speaker. Speaker,
▶ Play
Speaker 23 24:50
you've gone up, Mr. Chairman. Well, you know. I'm answering to a lot of things today, I
▶ Play
promise you. I know this question was asked, but I can't remember what the answer was they get $204 a month right? Is that per child
▶ Play
Speaker 30 25:12
or is that $204? Yes ma'am I'll answer that question. That's $204 per month per household that's depending on the composition of the household. In other words 204 a month is for a family of three. So that would be, that's how we determine. Okay, thank you. Representative
▶ Play
Fyte, you're recognized. Thank you, Mr. Chair. My question would be, if we have an adult in the household who may be the only adult in the household who is diverting funds that should be going to feed his or her family and provide for their needs, and instead using those funds for drugs, is that not a major problem? it is a major problem we also
▶ Play
have it set up in the bill if one of the parents is doing the drugs then the funds would go over to the controlling and if it's not if it's a single parent household we have it set up where it would go to grandparents or aunt or some other adult in charge but I'll save the rest of my comments
▶ Play
for close Representative Henderson we're back to you you're good all right seeing no one else to speak and and thank you for your testimony miss little I have no one else signed up speak for or against this bill would you like to close for the bill Senator Johnson represent lunch from whichever both of you I think
▶ Play
I just lost the coin toss and I would like to close for this bill and what I would like to do with this bill is to have it be a deterrent there is a cost yes but there's also a cost of the state of Arkansas when we have children in a home where drugs are being used where we have families that are being ripped apart by drugs yes we may not catch everybody the screening in this we only are asking a few questions if they're flagged for drugs then they get tested my concern is what is the physical impact to the taxpayers in the state of Arkansas when we have children they're in the influence of a home that someone is doing drugs we're not testing for drop for broad spectrum we're testing for five specific drugs this is a pilot study. What we want to find out is the ripple in the pond effect. If you throw a rock in the pond, the ripples are huge. If we stop drugs and are a deterrent for drugs at one point, what is the impact on the down the road? How can we save money? What is the deterrent? I realize there's a cost, but there's also a benefit. If we stop the cost of drugs in this state and start as a deterrent, where will it end? I don't know. We'll find out. That's why the pilot program. Thank you. All right, members, you've heard
▶ Play
an explanation of the bill. What is will of the committee? We have a motion to do pass from Representative Payton. Any discussion on that motion itself? Hearing or seeing none, all in favor say aye. All opposed? Ayes have it. Congratulations, the bill is passed. Representative Dotson, you're here for Senator Hester's bill. Is that right? And tell us that bill number. Senate Bill 754. As soon as we find 754, Representative Dodson, you'll be recognized to... I don't find it yet. Ah, there it is. Is that amendment engrossed? I bet it is. Yes, it is. Yeah, amendments and gross, do
▶ Play
you recognize, present the bill, Representative Dotson. Thank you, Mr. Chair,
▶ Play
Speaker 78 28:59
members of the committee. I will try to keep this fairly brief in a nutshell and expand beyond that if you so desire. Basically what this bill does, if you recall, a little earlier in the session, we had a bill very similar to this for plumbers where we expanded the amount of oversight on an apprentice from a one-to-one ratio to a one-to-three ratio. Well, the electricians would like to have the same sort of benefit, and so Senator Hester has worked with various groups to make sure that this is all in line with everybody from the Department of Labor and the various parties. There's no known opposition to this, and in a nutshell, it basically allows a master or a journeyman electrician to have a 1 to 3 supervisory ratio. That's in a nutshell what it does. And I'm open to any questions. Representative Dodson, we did this with plumbers earlier.
▶ Play
And after the bill passed out of this committee, I had a local master plumber call me. And the situation in northwest Arkansas is different than the situation in north central and probably a lot of other parts of the state. And his complaint was that it made the value of his master's license much less because, you know, he felt like a lot, or the journeyman's license, I'm sorry, the journeyman's license, because right now, you know, journeymen are being hired at, we'll use the number $20 an hour, but you can hire apprentices at, we'll say, $10 an hour. I don't know what the figures are. It doesn't matter. And so he felt like he was going to put a lot of journeymen out of work and is also going to create a lot less quality building being done. And that's why I voted against the bill on the House for it and work against it, but it made sense to me, that argument did. Is this a similar situation or we're going to have a number? I mean, am I going to get a call from an
▶ Play
Speaker 78 31:02
electrician in Mountain Home saying you just put a bunch of journeymen out of work? I cannot speak to the mindset of an electrician in Mountain Home. As of this moment, I am unaware of any oppositions to this bill from electricians or any other segment. And, of course, at the time I sat before this committee with regards to the plumbers, I hadn't heard of any opposition to it. with the plumbers either. So I know we discussed that after passed out a committee, and nobody had contacted me in regards to that on that bill or this one. So whether or not that would in that person's opinion lessen the value of his journeyman's pay, I mean, everyone's entitled to their own opinion. I don't necessarily know that's the case. I know in northwest Arkansas we have a shortage of a lot of building tradecraft-type individuals, and this will allow for more work to be done and more people to enter a field or an industry and hopefully increase the amount of jobs available and people entering into these fields. And I don't disagree
▶ Play
with you. I'm not jumping up and down and screaming. I'm just saying that argument was brought forward, and that argument made sense to me in my district especially. So that's why I wanted to at least bring this to you and bring it to the committee's attention. Representative Payton, I think you
▶ Play
have a question. You're recognized. Thank you, Mr. Chair. Representative Dotson, I'm just scanning through your bill real quick. And does it do more than just the change in apprentice ratio? Because the last two lines is all I see to affect that, but there's a lot of new language. And one particular thing I'd like for you to elaborate on is page 2. Line 16 and 17, talking about being within the line of sight. All right. Is this new regulations or further restrictions on
▶ Play
Speaker 78 33:04
how the apprentice operates? My understanding of it, this doesn't change much as far as any current regulation as far as the oversight of current or direct supervision requirements. But this does put it into code what those are. So as far as direct supervision, it details that out a little bit more in a line of sight requirements, which I don't know if those are necessarily in there. I do have someone here from the Department of Labor that can probably speak more directly to that if the Chair
▶ Play
Speaker 84 33:39
will recognize him. Absolutely. Thank you, Mr. Chairman. Daniel Faulkner, Staff Attorney, Arkansas Department of Labor. So with respect to your question, Representative Payton, generally the requirement right now on the regs is direct supervision. There's some differentiation between direct and then when you're working on energized parts, the reg actually says 50 feet when you're working on energized parts right now. But I would agree with the sponsor that it's generally not going to change much with respect to supervision. Okay. Thank you, Mr. Chair. Yes, sir. Members, any other questions? Seeing
▶ Play
none, we have no one signed up to speak for or against this bill, so we have one in the audience for or against this bill Seeing none, would you like to close for your bill Representative Dodson?
▶ Play
Just that I would appreciate a good vote Thank you, Mr.
▶ Play
Chair And will this committee? Representative Meeks has a motion to do pass Any discussion of that motion? Alright All in favor say aye All opposed? I'm going
▶ Play
to rule the eyes have that, barely, both of them, both eyes. Thank you, Mr. Chair, and both eyes.
▶ Play
Not a lot of enthusiasm for that one, Representative Dodson. Senator Irvin, you are recognized for Senate Bill 717. Thank you, Mr.
▶ Play
Chair. Thank you, members of committee. You have already passed this bill out, which I very much appreciate. And we've worked with, but we pulled it back to the House Committee to amend language in there for Representative McGee since his bill, we ran out of time to run his bill.
▶ Play
So we have an amendment that we are going to first hear, and Representative McGee has joined us at the table
▶ Play
Speaker 92 35:41
to explain the amendment? Correct. Okay. Thank you, Mr. Chair. Thank you, Committee. The essence of this bill is to bring strength to the Prescription Drug Monitoring Program, and what we added with the amendment were several things. We didn't change the original bill in terms of that language.
▶ Play
I hate to stop you, but hang on just a second, Representative McGee. I'm seeing a Senate amendment on the tablet, but I don't think we've got the House amendment in front of us yet. So let's give it just a moment, if you would. Okay. Let me make sure we're doing this to where we can see what we're doing. It's loading right now. Okay. All right, members. So Senate Bill 717, there's a new amendment on your tablet, 717-S1, or is that the other one? I'm sorry, J&B 395. That's the amendment that we're fixing to hear as soon as it pulls up. To enhance it, yeah. There we go. All right, now we've got a... It's a J&B one, J&B 396, members, underneath Senate Bill 717, and there's a lot of language in here. So give us just a moment more Representative McGee And we'll make sure everybody gets this pulled up Okay Alright Now if you would Kind of walk us through What this amendment
▶ Play
Speaker 91 37:22
does Okay This is just additional language to the original
▶ Play
Speaker 92 37:25
bill That kind of spells out Things a little bit more One of the things that it does is it asks the department or gives the department authority to develop algorithms to alert a practitioner if his or her patient is being prescribed opioid drugs by more than three physicians within a 30-day period. All of these things, all of this is designed to monitor and try to decrease prescription drug abuse. it provides that if a prescriber whoever that is is found by their own licensing board to be in violation of rule or regulation of that board that prescriber then is reported to the prescription monitoring board and and what that in essentially means is that then whenever they prescribe an opioid, they then are required to access the patient information on every individual patient. So you have a provider that's been sanctioned by their own board. They have to go, but the prescription monitoring program has to know that. And then when that prescriber gives a patient a prescription, they have to go online through the program and access for every patient. It's just an attempt to decrease prescription drug abuse on the street, so to speak. Then another significant change is that this directs emergency room departments and hospitals through their emergency room department, their staff, and their hospital boards to direct prescribing guidelines for each individual hospital. So that's just another attempt to educate physicians and tell them, you know, this is what we expect for you to do in the emergency room department when you're prescribing opioids. And that's up to each individual institution to determine their own rule and regulation. We don't set that, but that just directs the institutions to do that. The next thing that it does is there's a section that all people that have prescriptive authority will have to have two hours of prescription education by their respective boards. I think that's a reasonable thing to ask for people that are prescribing narcotics. The next issue deals with the licensing boards for those boards that allow individuals to prescribe. And basically what this says is that the licensing boards, for whoever that group of providers are, will adopt rule and regulation that are at least as stringent as the Arkansas State Medical Boards concerning the use of narcotics and the treatment of pain. I think this is real important to get these boards. I think of everything in this bill, the addition, this is one of the most important pieces because this takes people out of their silos and their individual boards, and this is going to make our boards that have prescribers, that have those authorities, this is going to make these boards get together and just as we do in this room and talk around the table and do what's best for patients. It puts everybody on a level playing field. So I think that's really one of the things I really like about the amendment. So what else? There are some other issues in it with regards to the prescribers. We have a definition in this of chronic non-malignant pain. That's pain. I don't remember the exact definition. It's lasting more than three months, requiring certain dosages of medications. What this is going to require is that the appropriate licensing boards, when we talked about them developing rule and regulation, the appropriate licensing boards are going to have to require this of those prescribers in that they have to, at a minimum, check the prescriptive history of the patient. So I'm a prescriber. Every six months I have to go online, go to the monitoring program, and check that prescriptive history. Patients move around sometimes, and they'll go to Yaleville and get a prescription, and maybe two months later they're over in another town getting a prescription, and that's very difficult for prescribers to know that. So this really helps those that are prescribed. So basically every six months they have to check with Prescription Drug Monitoring Program and see what the patient's been doing, where they've been going, where they've been getting their prescriptions. It also requires for chronic pain that there's a signed pain contract with the patient, And at a minimum, that contract will have expectations that the prescriber has of the patient's behavior while they're doing that. Now, this does, it can even include random drug testing and random pill counts, if that's something that's necessary. This does not include patients that are on hospice programs or patients that are in a licensed health care facility or patients with a terminal condition. that requires that people that are in inpatient, outpatient, palliative care programs, those are all exempt from this. This is just to really address those patients that are being treated for what we describe as chronic non-malignant pain. So that's basically it. The last thing is it does give immunity to a prescriber or a hospital or a health care system who in good faith reports suspected drug diversion to the program, it gives them civil and criminal liability immunity. So that's really, it's kind of a long amendment, a lot to go through, but it takes a program that's, it really strengthens the prescription monitoring program, and it's a benefit to patients, it's a benefit to the prescribers. I
▶ Play
would just like to tell you guys from, I checked with the Bureau this morning, And as a state, we have spent over half a million dollars on the prescription drug monitoring program, according to BLR figures this morning. So my intent is if we're going to have that, we're going to spend that money. Let's make sure it's utilized to its best ability to really address the problems that are out there with prescription drug abuse. I know that you all have heard testimony this past session from Senator Raypert on a young man that died of a prescription drug overdose. due to a combination of medications and their farm parties, and that happens. And I've known about this for over, oh, my goodness, I would say I've known about those parties for about 15, 16 years because of dealing with my nieces and nephews that would come and tell me about this, and they were just shocked by them. So I'm here in Little Rock, and, you know, it's a serious, serious problem. And so I think you saw a firsthand reality picture of what's happening in our streets on prescription drug abuse. And I can tell you lots of different stories of prescriptions that have been stolen from our clinic, of medications that have been stolen from hospitals and pharmacies, and this really tightens it up. And a lot of that, the training that may be required can be counted towards CME, which is something that everybody has to do annually. So there wouldn't be a new licensing for that or new education commitment for that. It could be counted part of their CME. So we'll answer any questions. And the health department is also here, Robert Breck, who I initiated the bill with, and we've met with him. And he's, you want to say anything? He's thumbs up.
▶ Play
let me ask a question first and we'll move to you Representative Meeks and Representative Payton is next the patient evaluation part which is page 3 last couple lines and this is page 3 of the amendment which we've not yet adopted because it's a big thing I mean the amendment is four pages but a patient is being treated with controlled substances have to be returned every six months what is the current rule or law on that? There's not one. There's not one. Okay. With their, do most patients that are being treated for this type of control for chronic non-malignant pain, are they typically come in every about six months or every year? I mean, how often would they normally come in? I know it varies since there's no rule. It varies, I'm sure, but wouldn't Wouldn't they be seeing them fairly often anyway? And the reason I'm asking is I'm guessing a lot of these people are on either private option or Medicaid or something, or are we going to be driving up costs by making them come in twice a year? Go ahead.
▶ Play
Speaker 92 47:02
Mr. Speaker, if it pleases the committee, I'd like to ask Mr. David Roten to
▶ Play
Speaker 73 47:09
respond to your question. If you
▶ Play
Speaker 101 47:11
would, introduce yourself for the record. You recognize. David Roten, I'm the Executive Vice President for the Arkansas Medical Society. To answer your question, Mr. Chairman, the State Medical Board has regulations in place today for physicians treating chronic long-term pain that's non-malignant, and they're seen fairly regularly. So this shouldn't be an additional visit. It's mostly for if they're not being treated by a physician, if they're being treated by a physician assistant, an advanced practice nurse. You could potentially, and I don't know if this is possible or not, but potentially have dentists treating people for TMJ for a long-term basis. So if you're treating someone with opioids, pretty heavy-duty drugs, for more than three months, then they probably need to be being seen much more than once every six months,
▶ Play
and they probably already are. Well, that was kind of my question. Are they probably already being seen? this isn't a big population that we're suddenly driving into doctor's offices that weren't there. That's correct. So we shouldn't expect a whole lot more cost to those programs. Wouldn't expect any. Very good. Representative
▶ Play
Meeks, you're recognized. Thank you, Mr. Chair. And I'm going to be focusing on the section that you added that a licensing board shall adopt rules or at least as stringent as rules of the Arkansas State Medical Board. Has this been passed through any of these other boards that you're going to have to work with? And if so, what was there a reaction? If not, then that does give me cause of concern that we're adding this at the last moment without the consideration of other boards. I do agree that we probably need standards all across, but what I'm going to have a problem with is that if the Arkansas State Medical Board says we want to make this rule change and then we have to come before in the interim before public health and you have all these other boards who don't agree to it, I mean, are we going to be in a position of where we're going to have this huge issue, you know, with the other boards not getting on board with what the medical board actually wants to do. So if
▶ Play
Speaker 92 49:25
you could address that, I'd appreciate it. Well, Representative Meeks, I think it's incumbent upon us to do everything that we can to have these boards work together. I don't think that the rule and regulation that the medical board is going to adopt with regard to pain management would be something that other boards would really have an issue with. If you have, I just believe we need to get the boards together to eliminate, not to have multiple sets of rule and regulation for different boards, but to have something that's streamlined where every board knows where they stand. and you have to start somewhere. You have to start with some group or some entity such as we do. We sit down and talk all the time about legislation, and we may agree or not agree, but we come to an agreement. And I think that's my point in this is try to get everyone together and eliminate the silos that are out there. And not only that, but also to help. You're dealing with physicians on the state medical board, many of whom treat chronic pain. They deal with all the problems associated with that with our physician community. They have the greatest amount of experience, and we're just about to unleash in this state another group of providers that are going to be prescribing these medications. I don't think it's too much to ask their boards to coordinate with the state medical board
▶ Play
Speaker 101 50:55
and sit down and have meetings. and again David wrote from the medical society I would add that you've passed two bills out of this committee already this session that require the nursing board specifically to adopt similar rules to the medical board and that's probably the primary board that would be affected by anything in this bill yes sir represent
▶ Play
Payton you recognize for question thank you Mr. Chair
▶ Play
you just really got to the heart of my question there with your last answer but I'd ask that you elaborate a little bit on exactly how this amendment and the language affects the legislation we passed and the people that we expanded their prescriptive authority and what parts of this amendment were prompted by that passage. If you could elaborate on any of that, I'd appreciate it. First, it has absolutely nothing
▶ Play
Speaker 101 51:42
to do with this. We've been working on this bill for about four months, long before those bills were ever introduced. It just took us a long time to get it to you because it is somewhat complex, and we had to bring a lot of physician groups together to get them to agree to some of the provisions in here because we're actually asking the physicians of this state to step up to the plate and change their prescribing habits a little bit to help address the prescription drug program. There's nothing in this bill that should impact them in any way that they're not already impacted by as far as the APRNs, physician assistants. the physician assistants are regulated by the state medical board already they have separate regulations very few of them treat long-term chronic pain chronic non-malignant pain mostly it's physicians now going forward in the future if representative hammer's bill makes it all the way through the system and becomes law then you might have some more treating chronic long-term pain and in that case they would be affected by this but the provisions in this bill that affect them that relates to how the boards regulate the treatment of pain are virtually identical to what was in the earlier bills yes sir you
▶ Play
got a follow up so it's not going to require that they pay another license or do an extensive amount of schooling no sir thank you Mr. Chair Yes, sir. Representative
▶ Play
Ferguson, you're recognized. Thank you, Mr. Chair. I think it might be helpful if you would sort of, I know we're all very familiar with the Prescription Drug Monitoring Program, but maybe Senator Irvin, I know, if you could kind of walk us through how that's utilized in a doctor's office and why it's important to have the training to use it. And CME is Continuing Medical Education, by the way, for our acronym people. Thank
▶ Play
you. And I will also say just Representative Boyd as a local pharmacist. So you'll have a patient that may present, and I can speak from the clinic perspective, but also physicians that work in emergency rooms. And a lot of times you'll have physicians that will work in emergency rooms, sometimes in different areas and locations. And it was very quite normal, actually, to see the same patient show up in Heber Springs Emergency Room, in Newport Emergency Room. You know, the next weekend they might be in Batesville or in Stone County Medical Center. And when you're a resident and you're not making a whole lot of money, you're moonlighting in ERs when you're a doctor because you've got to pay med school debt, you probably have a family, you know. So a lot of times physicians are moonlighting in ERs, so they're covering those ER shifts. And it was quite normal to see, we would call them frequent flyers, and they would be frequent flyers and they would show up almost, you know, at every single emergency room trying to get prescription drugs, this level of prescription drugs. And so that's why I was a huge advocate of the prescription drug monitoring program because now that information is collected in one place so that it can be accessed by a physician in the clinic or in an emergency room to check to see if this is a frequent flyer. Or they also would bounce around from clinic to clinic to clinic. And when that happens, I can tell you, you know, that may be a patient that's really there. We want to see patients that need to be seen. And when you're trying to see 40 patients a day, there's not a whole lot of time to spend with a patient sometimes because of the way everything is now. I could go in a whole long story. But when you're having to deal with that, it's difficult because it takes away time from your patients that really need their doctor. And they need to see that, whether it's a doctor or we work with physician assistants, we also work with APNs. So whoever it is, they need to have that time to spend with those patients. So when you have people that abuse the system, and they abuse the system because they're addicted to prescription drugs, and that's the bottom line. And so we now need to be able to strengthen this program and really utilize it as a tool to prevent that and to try to put folks into a care situation. And really this is more of an update from Representative Link's question as well because, you know, that's what we're trying to stop. Also, you know, so you have people that are addicted to prescription drugs, but you also have people that are selling them on the black market. That is a huge industry in this state. I don't know how we could ever account for it, but it's out there. You've got people that are getting these prescriptions, They're showing up, you know, in emergency rooms or they're showing up in clinics and they're getting these prescriptions and then they're selling those on the black market. We had a prescription stolen from an elderly patient, from a relative, out of the clinic. We notified the local authorities and the pharmacists. We're always on the phone with the pharmacists and all of our, every day, my husband's on the phone with the pharmacists, I would say probably 20 times a day. He talks more to the pharmacists than he does me. Anyway, but within the hour, half of those pills had already been sold on the black market. Half within the hour had already been sold on the black market. So this, you know, I agree with the amendments, and I know the health department does as well, because this is something that we're really trying to address out there. And then if you want to go down to cost, I mean, the cost of drug overdoses is a lot of money on our system as well. So when they show up in the emergency room, and death. And I think, you know, that what Senator Raybert brought up was a valid reality. And it is happening to primarily our young people in the state. So I appreciate that. But it is used. It is checked. It gives us the ability to determine if this is a legitimate patient with legitimate concerns or if they're just here abusing the system. and that's really the bottom line thank you
▶ Play
as a follow-up i think you might explain i mean i understand that most family practice doctors and people who prescribe chronic pain meds have a pain contract but it's not required this would require it explain a little bit how a pain contract works with a patient well i i think you should probably answer that because we don't treat a whole lot
▶ Play
Speaker 101 58:42
in our. A pain contract is simply a document that the physician goes over with the patient that explains to the patient, number one, again, it only applies to chronic non-malignant pain patients. So you're treating them with a certain level of prescription drugs for more than three months. So anything less than that doesn't fall into this. So a contract with the patient for treatment of pain simply says you're being treated with very dangerous drugs. These are habit forming. You have to be careful. Here's what I'm going to do to you, for you as your physician. Here's what I expect you to do in return. And what's in the bill basically is very simple and it says that as a condition of me treating you for chronic long-term pain I may ask you to do drug tests periodically your analysis to make sure a make sure you're taking your drug that I'm prescribing b make sure you're not taking something else that I don't know about and then the second part of it is that we may do pill counts so if I if you're prescribed a 30-day supply of pills and two weeks later they're all gone either you're taking them or you're selling them or someone's taking them from you and selling them and we need to know
▶ Play
about that. I want to say follow up on that there are a lot of elderly patients that that is happening to. There are so many elderly patients who get a prescription for their pain medication that's legitimate pain medication, and their family members are stealing their pills from them and selling them. It happens over and over again. All right. Thank you all. Representative Payton.
▶ Play
Thank you, Mr. Chair. We are considering the adoption of the amendment. Could you tell us the difference in your bill if it's not amended or what the amendment does that the bill doesn't do without the amendment. You understand what
▶ Play
I'm saying? Okay, well, you've just heard the explanation of the amendment. So it's a prerogative of the committee if you want to adopt the amendment that was presented. My bill allowed for somebody else inside the clinic setting to be designated to also be able to access the prescription drug monitoring program in case the physician doesn't have time or the nurse practitioner doesn't have time or the physician assistant doesn't have time. So without the amendment, your
▶ Play
bill does not do any of the things that we've discussed?
▶ Play
No, it does not. Okay. Thank you,
▶ Play
Chair Unverified 1:01:28
Mr. Chair. All right, members. You've heard an explanation of the amendment itself. Any further questions on that? Seeing none, what's the will of the committee on the amendment? We have a motion to adopt the amendment. any discussion hearing none all in favor say aye all opposed the amendment is adopted technically Senator Irvin you're recognized to present your bill which you have done before and passed in this committee but we do need you to present this bill so we can vote on it as amended I would appreciate a good vote I assume that she is closed for that bill I have closed for my bill alright so I have a do pass as amended by Representative Overby. Any discussion of that motion? Seeing none, all in favor say aye. Aye. Any opposed? And we have passed Senate Bill 717 as amended and I think you're up next, Representative Ferguson, and that is Senator Teague's bill? 927. Senate Bill 927. Thank you, Mr. Chairman.
▶ Play
Thank you, committee. The concept behind this bill is very simple. it is the insurance commissioner is for us doing this it really just extends what they call a bulletin and puts it in statute but I will tell you the truth when they brought me the bill to run for the insurance department I couldn't understand the bill hardly and I am a dentist and I am on the health insurance oversight committee So the bill in itself is quite confusing. So that's why I passed out the bulletin that was passed last session. And the bulletin really just sort of corrected an oversight in the selling of insurance as it's supposed to be sold according to the essential health benefits. As most of you know, with the Affordable Care Act, there are essential health benefits that are required to be covered by insurance companies. And dental benefits for children, pediatric only, is one of the essential health benefits that's required to be carried by health insurance carriers. Well, when the Affordable Care Act was written, it was required that insurers on the exchange have this rule that allows dental insurance to be sold separately than the health insurance, but a few people who buy their insurance off the exchange, there wasn't this exclusion. So I'll give you a minute to read the bulletin. I think the really important part is on page 2, paragraph 4 or 3, however you look at that top a little bit. But all it does is codify the bulletin that they did last session in order to clean up how dental insurance can be sold. So while it's saying if you have insurance that you buy off the exchange, and a lot of dental insurance, a lot of health insurance companies don't carry dental insurance, but they're required to provide dental insurance, So it's saying they have to provide information to the family saying that their dental insurance is provided by a dental insurance company and not by the health insurance company itself. So if you have questions, I can answer them.
▶ Play
Chair Unverified 1:05:35
Representative Ferguson, Senator Flowers has been incredibly adamant on this issue. Does this resolve some of her pain that we've been able to listen to for so many hours? No, that's
▶ Play
really a separate issue. She's concerned about the private option aspect that Medicaid pays the premiums, and those dental benefits are part of the waiver population that Medicaid pays in addition to the private option insurance. This is strictly about private insurance. So this won't touch her concerns? No, it doesn't
▶ Play
Chair Unverified 1:06:10
have anything to do with that. And we're kind of getting off the bill for just a moment. Is
▶ Play
there anything going on in the session that does? Not that I know of. I
▶ Play
Chair Unverified 1:06:20
mean, I would think they would have told me since I'm a dentist. I would hope so. Members, questions for Representative Ferguson? Representative Sullivan,
▶ Play
you're recognized. Thank you, Mr. Chair. So I assume if this doesn't pass, we're just going to continue with the same problems, and we need this just as a...
▶ Play
Yeah, well, the bulletin expires, and I guess rather than issue a new bulletin, and according to the insurance commissioner, they wanted to codify it where the off-exchange and on-exchange insurances had the same dental benefit option. Right. Thank you, Mr. Chair. Seeing no other
▶ Play
Chair Unverified 1:06:53
questions, anyone sign to speak forward against this bill? Anyone in the audience speak forward against this bill? Seeing none coming forward, are you closed for your bill? I am closed. And what is will of this committee? Representative Overby, you have a motion to do pass. Is there any discussion of that motion? Seeing or hearing none, all in favor say aye. And all opposed? And this bill has passed. Thank you, committee. And I believe we have come to a point of celebration, members. I want to take a moment and think, you know, that we went through this entire session never losing a quorum one time. I mean it's impressive yeah well at one point in time we got down to ten members and we called somebody that's in the hall to make sure we kept a quorum that's very impressive members I mean it's we've sat here a lot of hours and discussed a lot of difficult issues so I'm very very proud of that because it takes participation and it's the hardest working committee in the legislature we always say that and this truly was we also have the hardest working staff and we appreciate them keeping us informed but even more importantly everybody that's still in this room and has been in this room all year long because most everybody's been at the end of the table in one way or another, whether it's the Department of Health or Mr. Selig or whether it's whoever it may be or Surgeon General and a number of lobbyists are trying to help us keep informed of their concerns and the concerns of that side so it's been a lot of work, a great deal of hard work and we really appreciate everybody. Mr. Rose, thank you for helping us keep the sound level down in this room That's also important because it gets quite noisy in here. So with all that said, thank you, everybody. And I don't think we'll be back here unless we have a concurrent amendment or something comes out of Senate that we have to have to hear.
▶ Play

Agenda

SB600

3:44 - 28:48 67 segments 12 speakers

SB754

28:48 - 35:17 24 segments 6 speakers

SB717

35:17 - 1:02:48 71 segments 9 speakers

SB927

1:02:48 - 1:08:41 17 segments 3 speakers

Documents

No documents posted.

Speakers

Chair Unverified
46 segments
Representative Kenneth B. Ferguson Unverified
16 segments
Speaker 5
1 segment
Speaker 13
6 segments
Speaker 21
7 segments
Speaker 23
2 segments
Speaker 24
1 segment
Speaker 30
6 segments
Speaker 28
1 segment
Representative Robin Lundstrum Unverified
6 segments
Representative Ken Bragg Unverified
1 segment
Speaker 48
20 segments
Representative Ken Henderson Unverified
7 segments
Representative Betty Overbey Unverified
2 segments
Representative Lanny Fite Unverified
2 segments
Representative Jim Dotson Unverified
3 segments
Speaker 78
8 segments
Representative John Payton Chair Unverified
7 segments
Speaker 84
2 segments
Senator Missy Irvin Unverified
18 segments
Speaker 92
18 segments
Speaker 91
1 segment
Speaker 73
1 segment
Speaker 101
10 segments
Representative Stephen Meeks Unverified
3 segments
Representative Dan Sullivan Unverified
1 segment